Oligovax
  • Home
  • Shop
  • Biosci™ Lymphocyte Separation Tube for Human Peripheral Blood
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • 0
  • +33 1 43 25 01 50
  • Sign in
  • Contact Us
Oligovax
  • 0
  • 0
    • Home
    • Shop
    • Biosci™ Lymphocyte Separation Tube for Human Peripheral Blood
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +33 1 43 25 01 50
  • Sign in
  • Contact Us
Protein Secondary Structure Prediction using Neural Networks
 
  • Blogs:
  • All
  • Custom Recombinant Protein Production
  • NaTtrol
  • News
  • Success Stories
  • Protein Secondary Structure Prediction using Neural Networks
  • Custom Recombinant Protein Production
  • Diseases Testing
  • DNA purification
  • T7 RNA Polymerase
  • Vaccine research
  • Mycoplasma TIES
Protein Secondary Structure Prediction using Neural Networks
Gen store
Protein Secondary Structure Prediction using Neural Networks
Protein Secondary Structure Prediction using Neural Networks...
Mar 15, 2024

Oligovax SAS

Operator of a biopharmaceutical company intended to provide therapies for cancer. The company develops drug substances consisting of synthetic oligonucleotides (ODNs) containing cytosine-guanine dinucleotide (CpG) motifs that have optimized immunostimulating properties, helping healthcare practitioners to cure patients suffering from cancer.

Oligovax SAS

Gentaur Group

  • 9 Rue Lagrange, 75005 Paris, France.
  • +33 1 43 25 01 50
  • info@oligovax.com
Follow us
Copyright © Oligovax